Cogent Biosciences, Inc. Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cogent Biosciences, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Cogent Biosciences, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $64.4M, a 36.7% increase year-over-year.
  • Cogent Biosciences, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $245M, a 43.1% increase year-over-year.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2023 was $208M, a 40.8% increase from 2022.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2022 was $148M, a 95.7% increase from 2021.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2021 was $75.6M, a 16.1% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $208M +$60.3M +40.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $148M +$72.3M +95.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $75.6M -$14.5M -16.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $90.1M +$35.4M +64.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $54.7M +$8.94M +19.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $45.7M +$11.2M +32.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $34.5M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.